scholarly journals Effects of SARS-CoV-2 on the endocrine system

2021 ◽  
Vol 5 (9) ◽  
pp. 575-578
Author(s):  
N.A. Petunina ◽  
◽  
A.S. Shkoda ◽  
M.E. Telnova ◽  
E.V. Goncharova ◽  
...  
Keyword(s):  
Adrenal Insufficiency ◽  
Transmembrane Protein ◽  
Severe Disease ◽  
Endocrine System ◽  
Long Term Effects ◽  
Secondary Adrenal Insufficiency ◽  
Euthyroid Sick Syndrome ◽  
Obesity And Diabetes ◽  
Russian Medical

SARS-CoV-2 rapidly spread worldwide and resulted in an unprecedented pandemic. Considering the novelty of this disease, its potential effects on the endocrine system remain elusive. This virus is known to utilize the extracellular domain of angiotensin-converting enzyme (ACE) and transmembrane protein TMPRSS2. Broad expression of ACE-2 and TMPRSS2 is a potential cause of extrapulmonary manifestations of SARSCoV- 2, including endocrine ones. The most common presentations are direct or indirect damage of the endocrine part of the pancreas, hypothalamicpituitary- adrenal and hypothalamic-pituitary-thyroid axes, and possible long-term effects on the reproductive system. It was demonstrated that obesity and diabetes increase the risk of severe course and death in COVID-19. Similarly, patients with transitory hyperglycemia have a higher risk of severe disease course. Primary and secondary adrenal insufficiency of various origins potentially accounts for severity. The most common thyroid complications of the COVID-19 infection are euthyroid sick syndrome and transient destructive thyroiditis, including subacute thyroiditis. KEYWORDS: SARS-CoV-2, COVID-19, endocrinopathies, diabetes, adrenal insufficiency. FOR CITATION: Petunina N.A., Shkoda A.S., Telnova M.E. et al. Effects of SARS-CoV-2 on the endocrine system. Russian Medical Inquiry. 2021;5(9):575–578 (in Russ.). DOI: 10.32364/2587-6821-2021-5-9-575-578.

scholarly journals SARS-CoV-2 (COVID-19) and the Endocrine System

2020 ◽  
Vol 4 (11) ◽  
Author(s):  
Michelle D Lundholm ◽  
Caroline Poku ◽  
Nicholas Emanuele ◽  
Mary Ann Emanuele ◽  
Norma Lopez
Keyword(s):  
Severe Disease ◽  
Clinical Manifestations ◽  
Endocrine System ◽  
The Body ◽  
Active Area ◽  
Gonadal Function ◽  
Long Term Effects ◽  
The World ◽  
The Impact

Abstract As SARS-CoV-2 (COVID-19) overtakes the world, causing moderate to severe disease in about 15% of infected patients, COVID-19 is also found to have widespread effects throughout the body with a myriad of clinical manifestations including the endocrine system. This manuscript reviews what is known about the impact of COVID-19 on the pathophysiology and management of diabetes (both outpatient and inpatient) as well as pituitary, adrenal, thyroid, bone, and gonadal function. Findings in this area are evolving, and long-term effects of infection remain an active area of further research.

The Effect of Probiotics Supplementation in Maternal-Fetal Care

2020 ◽  
Vol 16 ◽  
Author(s):  
Mahnaz Mardani ◽  
Sadegh Rezapour
Keyword(s):  
Diabetes Mellitus ◽  
Protective Role ◽  
Optimum Dose ◽  
Active Living ◽  
Maternal Weight Gain ◽  
Long Term Effects ◽  
Maternal Weight ◽  
Human Gut ◽  
Obesity And Diabetes

: Pregnancy-related complications can have long-term effects on mother and fetus/child. Microbiome within the human gut is an important factor to maintain optimum health during pregnancy and could possibly reduce the incidence of these complications. Probiotics are active living microorganisms that can provide the host with health benefits such as; immune and hormonal regulatory and metabolic benefits when administered in adequate and optimum dose. Probiotic supplementations also regulate abnormal and unbalanced microflora population that can control the pathogenesis of several diseases like obesity and diabetes. Probiotics also play a protective role in complications like preeclampsia, gestational diabetes mellitus and maternal weight gain and enhance successful outcomes of reproduction. This mini review will thereby summarize the maternal and fetal effects of probiotics during pregnancy.

scholarly journals Secondary Adrenal Insufficiency after Treatment with Budesonide for Autoimmune Hepatitis

2018 ◽  
Vol 12 (3) ◽  
pp. 597-601 ◽  
Author(s):  
Filip De Maeyer ◽  
Bruno Lapauw ◽  
Anne Hoorens ◽  
Anja Geerts ◽  
Hans Van Vlierberghe ◽  
...  
Keyword(s):  
Autoimmune Hepatitis ◽  
Adrenal Insufficiency ◽  
Attractive Alternative ◽  
Secondary Adrenal Insufficiency ◽  
Systemic Activity ◽  
Immunosuppressive Medication ◽  
Systemic Corticosteroids ◽  
First Case ◽  
First Pass

Autoimmune hepatitis (AIH) is a rare cause of chronic liver disease. The backbone of treatment is immunosuppressive medication, typically prednisolone as induction therapy and azathioprine as a maintenance therapy. Side effects of the long-term use of systemic corticosteroids are well known and have led to the use of alternative induction regimens. An attractive alternative is budesonide, a nonhalogenated glucocorticosteroid characterized by a high first-pass effect in the liver (90%), resulting in a high topical anti-inflammatory activity and a low systemic activity. It should be stressed that budesonide is contraindicated in patients with established cirrhosis with portal hypertension and portocaval shunting. In this case report, we present the first case of adrenal insufficiency following treatment with budesonide for AIH.

scholarly journals Approach to stress endocrine response: somatization in the context of gastroenterological symptoms: a systematic review

2019 ◽  
Vol 19 (3) ◽  
pp. 2537-2545
Author(s):  
Gülseren Keskin
Keyword(s):  
Stress Responses ◽  
Stressful Life Events ◽  
Physiological Stress ◽  
Gastrointestinal Symptoms ◽  
Endocrine System ◽  
Traumatic Experiences ◽  
Long Term Effects ◽  
Endocrine Response ◽  
Response To Stress

Background: Stress can be defined as an acute threat to the homeostasis of an organism, and in order to manage stress, and maintain stability, the allostatic systems activate an adaptive response. Stress has been shown to have both short - and long-term effects on the function of the gastrointestinal tract, but long-term exposure to stress is more likely to cause endocrine disorders.Objective: The aim of this study was to investigate the endocrine response to stress, and evaluate the relationship between somatization and gastrointestinal symptoms.Methods: A systematic literature search was conducted on several academic databases, which included, Pubmed, EBSCO and Science Direct. The search was performed using the keywords, “endocrine response to stress”, “somatization” and “gastrointestinal symptoms”. Results: The hypothalamic-pituitary-adrenal (HPA) axis is essential in controlling physiological stress responses. Dysfunction is related to several mental disorders, including anxiety and depression, or somatization. Symptoms associated with genetic, or other traumatic experiences of individuals under stress, can lead to a maladaptive response to stress. These stressful life events were found to be associated with digestive system-related chronic diseases. Gastrointestinal disorders significantly affect millions of people worldwide. Conclusion: This study examined how the endocrine system responds to stress, and the effect this has in causing stress-related gastrointestinal distresses. Our findings indicate that stress-related psychological disorders are strongly associated with the severity of gastrointestinal symptoms.Keywords: Stress, endocrine response, somatization, gastrointestinal symptoms.

scholarly journals P.089 Recovery from chronic secondary adrenal insufficiency in patients with pituitary disorders

2016 ◽  
Vol 43 (S2) ◽  
pp. S41-S41
Author(s):  
V Munro ◽  
B Tugwell ◽  
S Doucette ◽  
DB Clarke ◽  
A Lacroix ◽  
...  
Keyword(s):  
Adrenal Insufficiency ◽  
Tumour Size ◽  
Pituitary Surgery ◽  
Complete Recovery ◽  
Glucocorticoid Therapy ◽  
Hormone Deficiency ◽  
Secondary Adrenal Insufficiency ◽  
Glucocorticoid Treatment ◽  
Acth Secreting

Background: Patients with pituitary disorders may be placed on steroid replacement for secondary adrenal insufficiency (SAI), generally after pituitary surgery; however, data regarding recovery of long-term SAI are lacking. We conducted a study to assess the longer term recovery rate of SAI in patients with pituitary disorders. Methods: We identified all SAI patients from prospectively entered data in the Halifax Neuropituitary Database from November 1, 2005 to September 30, 2014, who had required glucocorticoid therapy for >3 months, and a minimum follow-up of 6 months. Exclusion: ACTH-secreting adenomas; peri-operative glucocorticoid treatment only; glucocorticoids for non-pituitary conditions. Results: 55 patients fulfilled the criteria, 41 (75%) of which had transsphenoidal surgery. Nine (16.4%) patients had complete recovery of SAI over a median of 20 months (range: 8–51). Smaller tumour size and initial cortisol >175 nmol/L had increased likelihood of recovery; those with secondary hypogonadism or growth hormone deficiency were less likely to recover. Conclusions: This is the first study to examine long-term recover of SAI in patients with pituitary disorders: approximately 1 in 6 patients recover adrenal function, up to 5 years after diagnosis. Consequently, patients with SAI should undergo regular testing to prevent unnecessary chronic glucocorticoid therapy.

scholarly journals Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection

2021 ◽  
Vol 27 (1) ◽  
Author(s):  
Catherine Chen ◽  
Aisah Amelia ◽  
George W. Ashdown ◽  
Ivo Mueller ◽  
Anna K. Coussens ◽  
...  
Keyword(s):  
Severe Disease ◽  
Surface Proteins ◽  
Prognostic Indicators ◽  
Individual Risk ◽  
Long Term Effects ◽  
Complement Components ◽  
Screening Strategies ◽  
Life Threatening ◽  
Asymptomatic Infections

AbstractCOVID-19 clinical presentation differs considerably between individuals, ranging from asymptomatic, mild/moderate and severe disease which in some cases are fatal or result in long-term effects. Identifying immune mechanisms behind severe disease development informs screening strategies to predict who are at greater risk of developing life-threatening complications. However, to date clear prognostic indicators of individual risk of severe or long COVID remain elusive. Autoantibodies recognize a range of self-antigens and upon antigen recognition and binding, important processes involved in inflammation, pathogen defence and coagulation are modified. Recent studies report a significantly higher prevalence of autoantibodies that target immunomodulatory proteins including cytokines, chemokines, complement components, and cell surface proteins in COVID-19 patients experiencing severe disease compared to those who experience mild or asymptomatic infections. Here we discuss the diverse impacts of autoantibodies on immune processes and associations with severe COVID-19 disease.

scholarly journals Steroids and TRP Channels: A Close Relationship

2020 ◽  
Vol 21 (11) ◽  
pp. 3819
Author(s):  
Karina Angélica Méndez-Reséndiz ◽  
Óscar Enciso-Pablo ◽  
Ricardo González-Ramírez ◽  
Rebeca Juárez-Contreras ◽  
Tamara Rosenbaum ◽  
...  
Keyword(s):  
Transient Receptor Potential ◽  
Cell Function ◽  
Trp Channels ◽  
Protein Complexes ◽  
Transmembrane Protein ◽  
Receptor Potential ◽  
Long Term Effects ◽  
Close Relationship ◽  
Transient Receptor

Transient receptor potential (TRP) channels are remarkable transmembrane protein complexes that are essential for the physiology of the tissues in which they are expressed. They function as non-selective cation channels allowing for the signal transduction of several chemical, physical and thermal stimuli and modifying cell function. These channels play pivotal roles in the nervous and reproductive systems, kidney, pancreas, lung, bone, intestine, among others. TRP channels are finely modulated by different mechanisms: regulation of their function and/or by control of their expression or cellular/subcellular localization. These mechanisms are subject to being affected by several endogenously-produced compounds, some of which are of a lipidic nature such as steroids. Fascinatingly, steroids and TRP channels closely interplay to modulate several physiological events. Certain TRP channels are affected by the typical genomic long-term effects of steroids but others are also targets for non-genomic actions of some steroids that act as direct ligands of these receptors, as will be reviewed here.

scholarly journals Endocrine-Disrupting Chemicals and Infectious Diseases: from Endocrine Disruption to Immunosuppression

2021 ◽  
Vol 22 (8) ◽  
pp. 3939
Author(s):  
Elikanah Olusayo Adegoke ◽  
Md Saidur Rahman ◽  
Yoo-Jin Park ◽  
Young Ju Kim ◽  
Myung-Geol Pang
Keyword(s):  
Immune System ◽  
Influenza A ◽  
Scientific Evidence ◽  
Severe Disease ◽  
Endocrine Disrupting Chemicals ◽  
Endocrine System ◽  
Consumer Products ◽  
Adverse Health Effects ◽  
Endocrine Disrupting

Endocrine-disrupting chemicals (EDCs) are hormonally active compounds in the environment that interfere with the body’s endocrine system and consequently produce adverse health effects. Despite persistent public health concerns, EDCs remain important components of common consumer products, thus representing ubiquitous contaminants to humans. While scientific evidence confirmed their contribution to the severity of Influenza A virus (H1N1) in the animal model, their roles in susceptibility and clinical outcome of the coronavirus disease (COVID-19) cannot be underestimated. Since its emergence in late 2019, clinical reports on COVID-19 have confirmed that severe disease and death occur in persons aged ≥65 years and those with underlying comorbidities. Major comorbidities of COVID-19 include diabetes, obesity, cardiovascular disease, hypertension, cancer, and kidney and liver diseases. Meanwhile, long-term exposure to EDCs contributes significantly to the onset and progression of these comorbid diseases. Besides, EDCs play vital roles in the disruption of the body’s immune system. Here, we review the recent literature on the roles of EDCs in comorbidities contributing to COVID-19 mortality, impacts of EDCs on the immune system, and recent articles linking EDCs to COVID-19 risks. We also recommend methodologies that could be adopted to comprehensively study the role of EDCs in COVID-19 risk.

Sign in / Sign up

Export Citation Format

Share Document